Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation
Hall, Terence G, Yu, Yi, Eathiraj, Sudharshan, Wang, Yunxia, Savage, Ronald E, Lapierre, Jean-Marc, Schwartz, Brian, Abbadessa, Giovanni
Published in PloS one (14.09.2016)
Published in PloS one (14.09.2016)
Get full text
Journal Article
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Santoro, Armando, MD, Rimassa, Lorenza, Dr, Borbath, Ivan, MD, Daniele, Bruno, MD, Salvagni, Stefania, MD, Van Laethem, Jean Luc, Prof, Van Vlierberghe, Hans, MD, Trojan, Jörg, Prof, Kolligs, Frank T, Prof, Weiss, Alan, Prof, Miles, Steven, MD, Gasbarrini, Antonio, Prof, Lencioni, Monica, MD, Cicalese, Luca, MD, Sherman, Morris, MD, Gridelli, Cesare, MD, Buggisch, Peter, MD, Gerken, Guido, Prof, Schmid, Roland M, Prof, Boni, Corrado, MD, Personeni, Nicola, MD, Hassoun, Ziad, MD, Abbadessa, Giovanni, MD, Schwartz, Brian, MD, Von Roemeling, Reinhard, MD, Lamar, Maria E, BA, Chen, Yinpu, PhD, Porta, Camillo, MD
Published in The lancet oncology (2013)
Published in The lancet oncology (2013)
Get full text
Journal Article
Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092
Yu, Yi, Savage, Ronald E, Eathiraj, Sudharshan, Meade, Justin, Wick, Michael J, Hall, Terence, Abbadessa, Giovanni, Schwartz, Brian
Published in PloS one (15.10.2015)
Published in PloS one (15.10.2015)
Get full text
Journal Article
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model
Kurma, Keerthi, Zeybek Kuyucu, Ayca, Roth, Gaël S, Sturm, Nathalie, Mercey-Ressejac, Marion, Abbadessa, Giovanni, Yu, Yi, Lerat, Herve, Marche, Patrice N, Decaens, Thomas, Macek Jilkova, Zuzana
Published in International journal of molecular sciences (19.12.2022)
Published in International journal of molecular sciences (19.12.2022)
Get full text
Journal Article
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs
Soncini, Debora, Orecchioni, Stefania, Ruberti, Samantha, Minetto, Paola, Martinuzzi, Claudia, Agnelli, Luca, Todoerti, Katia, Cagnetta, Antonia, Miglino, Maurizio, Clavio, Marino, Contini, Paola, Varaldo, Riccardo, Bergamaschi, Micaela, Guolo, Fabio, Passalacqua, Mario, Nencioni, Alessio, Monacelli, Fiammetta, Gobbi, Marco, Neri, Antonino, Abbadessa, Giovanni, Eathiraj, Sudharshan, Schwartz, Brian, Bertolini, Francesco, Lemoli, Roberto M, Cea, Michele
Published in Haematologica (Roma) (01.10.2020)
Published in Haematologica (Roma) (01.10.2020)
Get full text
Journal Article
ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease
Kim, Kyungho, Li, Jing, Barazia, Andrew, Tseng, Alan, Youn, Seock-Won, Abbadessa, Giovanni, Yu, Yi, Schwartz, Brian, Andrews, Robert K, Gordeuk, Victor R, Cho, Jaehyung
Published in Haematologica (Roma) (01.02.2017)
Published in Haematologica (Roma) (01.02.2017)
Get full text
Journal Article
Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
Roth, Gaël S, Macek Jilkova, Zuzana, Zeybek Kuyucu, Ayca, Kurma, Keerthi, Ahmad Pour, Séyédéh Tayébéh, Abbadessa, Giovanni, Yu, Yi, Busser, Benoit, Marche, Patrice N, Leroy, Vincent, Decaens, Thomas
Published in Molecular cancer therapeutics (01.10.2017)
Published in Molecular cancer therapeutics (01.10.2017)
Get full text
Journal Article
Isatuximab monotherapy in patients with refractory T‐acute lymphoblastic leukemia or T‐lymphoblastic lymphoma: Phase 2 study
Boissel, Nicolas, Chevallier, Patrice, Doronin, Vadim, Griskevicius, Laimonas, Maschan, Alexey, McCloskey, James, Rambaldi, Alessandro, Rossi, Giuseppe, Sokolov, Andrey, Wartiovaara‐Kautto, Ulla, Oprea, Corina, Abbadessa, Giovanni, Gosselin, Alice, Macé, Sandrine, Thomas, Xavier
Published in Cancer medicine (Malden, MA) (01.03.2022)
Published in Cancer medicine (Malden, MA) (01.03.2022)
Get full text
Journal Article
Combination of the c-Met inhibitor tivantinib and zoledronic acid prevents tumor bone engraftment and inhibits progression of established bone metastases in a breast xenograft model
Previdi, Sara, Scolari, Federica, Chilà, Rosaria, Ricci, Francesca, Abbadessa, Giovanni, Broggini, Massimo
Published in PloS one (18.11.2013)
Published in PloS one (18.11.2013)
Get full text
Journal Article
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study
Zucali, Paolo Andrea, Lin, Chia-Chi, Carthon, Bradley C, Bauer, Todd M, Tucci, Marcello, Italiano, Antoine, Iacovelli, Roberto, Su, Wu-Chou, Massard, Christophe, Saleh, Mansoor, Daniele, Gennaro, Greystoke, Alastair, Gutierrez, Martin, Pant, Shubham, Shen, Ying-Chun, Perrino, Matteo, Meng, Robin, Abbadessa, Giovanni, Lee, Helen, Dong, Yingwen, Chiron, Marielle, Wang, Rui, Loumagne, Laure, Lépine, Lucie, de Bono, Johann
Published in Journal for immunotherapy of cancer (01.01.2022)
Published in Journal for immunotherapy of cancer (01.01.2022)
Get full text
Journal Article
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study
Baranda, Joaquina C., Robbrecht, Debbie, Sullivan, Ryan, Doger, Bernard, Santoro, Armando, Barve, Minal, Grob, Jean‐Jacques, Bechter, Oliver, Vieito, Maria, Miguel, Maria Jose, Schadendorf, Dirk, Johnson, Melissa, Pouzin, Clemence, Cantalloube, Cathy, Wang, Rui, Lee, Jooyun, Chen, Xiaofei, Demers, Brigitte, Amrate, Amele, Abbadessa, Giovanni, Hodi, F. Stephen
Published in Clinical and translational science (01.06.2024)
Published in Clinical and translational science (01.06.2024)
Get full text
Journal Article
Biomarker and pharmacodynamic activity of the transforming growth factor‐beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors
Robbrecht, Debbie, Grob, Jean‐Jacques, Bechter, Oliver, Simonelli, Matteo, Doger, Bernard, Borbath, Ivan, Butler, Marcus O., Cheng, Tina, Romano, Patricia Martin, Pons‐Tostivint, Elvire, Di Nicola, Massimo, Curigliano, Giuseppe, Ryu, Min‐Hee, Rodriguez‐Vida, Alejo, Schadendorf, Dirk, Garralda, Elena, Abbadessa, Giovanni, Demers, Brigitte, Amrate, Amele, Wang, Hong, Lee, Joon Sang, Pomponio, Robert, Wang, Rui
Published in Clinical and translational science (01.02.2024)
Published in Clinical and translational science (01.02.2024)
Get full text
Journal Article
779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors
Gutierrez, Martin, Garralda, Elena, Calvo, Emiliano, Dongen, Marloes van, Eskens, Ferry, Finlay, Morgan, Menas, Fatima, Zhu, Chen, Wu, Meijing, Guillemin-Paveau, Helene, Abbadessa, Giovanni, Perez, Raymond, Yildirim, Ozlem, Naing, Aung
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors
Luke, Jason, Olszanski, Anthony J, Rosen, Lee, Tarhini, Ahmad A, Baakili, Adyb, Wagenaar, Timothy, Zhu, Chen, Guillemin-Paveau, Helene, Wu, Meijing, Perez, Raymond, Abbadessa, Giovanni, Fountzilas, Christos
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
Personeni, Nicola, Giordano, Laura, Abbadessa, Giovanni, Porta, Camillo, Borbath, Ivan, Daniele, Bruno, Van Laethem, Jean-Luc, Van Vlierberghe, Hans, Trojan, Jörg, De Toni, Enrico N, Gasbarrini, Antonio, Lencioni, Monica, Lamar, Maria E, Wang, Yunxia, Shuster, Dale, Schwartz, Brian, Santoro, Armando, Rimassa, Lorenza
Published in Oncotarget (28.02.2017)
Published in Oncotarget (28.02.2017)
Get full text
Journal Article
551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers
John, PARK, Baakili, Adyb, Demers, Brigitte, Saleem, Rao, Gosselin, Alice, Abbadessa, Giovanni, Ascierto, Paolo A
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
P494: A FIRST‐IN‐HUMAN STUDY OF CD123 NK CELL ENGAGER SAR443579 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH RISK‐MYELODYSPLASIA
Selwyn Stein, Anthony, Jongen‐Lavrencic, Mojca, Garciaz, Sylvain, A Huls, Gerwin, Maiti, Abhishek, Boissel, Nicolas, De Botton, Stephane, Fleming, Shaun, Michel Zwaan, C., C. de Leeuw, David, Desai, Pinkal, Lucia Arellano, Martha, Avigan, David, Langemeijer, Saskia, Jensen, Kyle, Wagenaar, Timothy, MI, Gu, Abbadessa, Giovanni, Bajel, Ashish
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS
Baruchel, André, Bertrand, Yves, Nysom, Karsten, Jin Kang, Hyoung, Makiya, Monica, Abrahamsson, Jonas, González‐Llano, Oscar, Quinones Choque, Willy, Rizzari, Carmelo, Buechner, Jochen, Cesaro, Simone, Duarte, Ximo, Fagioli, Franca, Kattamis, Antonis, Leverger, Guy, Nelken, Brigitte, Wang, Lynn, Mace, Sandrine, Oprea, Corina, Abbadessa, Giovanni, Zwaan, Michel
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Optimized management of advanced hepatocellular carcinoma:Four long-lasting responses to sorafenib
Abbadessa, Giovanni, Rimassa, Lorenza, Pressiani, Tiziana, Carrillo-Infante, Cynthia, Cucchi, Emanuele, Santoro, Armando
Published in World journal of gastroenterology : WJG (21.05.2011)
Published in World journal of gastroenterology : WJG (21.05.2011)
Get full text
Journal Article